跳到正文

Blue Owl Capital Holdings LP 13F 持仓 · 2026年Q2

Blue Owl Capital Holdings 在 2026年Q2(报告期截至 2026-06-30)的 SEC 13F 申报中报告了 71 只证券,申报市值合计 6.65 亿美元。前几大持仓:SPCX(35.97%)、AKTS(14.89%)、CGEM(4.22%)。本季前 25 大持仓中:新建仓 6 只、增持 7 只、减持 8 只。

排名代码公司市值占组合股数变动
1SPCXSPACE EXPLORATION TECHN CORP$239.0M35.97%1.4M新建仓
2AKTSAKTIS ONCOLOGY INC$99.0M14.89%3.1M减持
3CGEMCULLINAN THERAPEUTICS INC$28.0M4.22%1.5M减持
4LRMRLARIMAR THERAPEUTICS INC$27.9M4.21%9.2M增持
5NCDLNUVEEN CHURCHILL DIRECT LEND$26.6M4.01%2.1M持平
6MPLTMAPLIGHT THERAPEUTICS INC$26.2M3.94%729,929减持
7COFCAPITAL ONE FINL CORP$24.0M3.62%119,757新建仓
8OBDCBLUE OWL CAPITAL CORPORATION$22.2M3.35%2.0M持平
9FISNDEEP FISSION INC$14.7M2.22%1.3M新建仓
10DELLDELL TECHNOLOGIES INC$14.2M2.14%32,961增持
11HLLYHOLLEY INC$11.2M1.68%4.4M增持
12EYPTEYEPOINT INC$10.9M1.64%762,594减持
13SGMTSAGIMET BIOSCIENCES INC$9.7M1.47%1.3M增持
14CRVSCORVUS PHARMACEUTICALS INC$9.1M1.37%608,600增持
15ARTVARTIVA BIOTHERAPEUTICS INC$8.5M1.28%874,542新建仓
16CMPXCOMPASS THERAPEUTICS INC$7.9M1.19%3.6M增持
17CNDTCONDUENT INC$7.4M1.11%5.0M持平
18RYTMRHYTHM PHARMACEUTICALS INC$6.8M1.03%61,455持平
19CMPSCOMPASS PATHWAYS PLC$6.4M0.96%450,000新建仓
20RAREULTRAGENYX PHARMACEUTICAL IN$6.1M0.92%182,638减持
21PVLAPALVELLA THERAPEUTICS INC NE$5.5M0.83%36,259增持
22IMAIMAGENEBIO INC$5.4M0.81%917,692减持
23CMPSCOMPASS PATHWAYS PLC$5.2M0.78%1.7M减持
24VRDNVIRIDIAN THERAPEUTICS INC$4.8M0.72%260,000新建仓
25IMMXIMMIX BIOPHARMA INC$4.5M0.68%437,552减持

来源:SEC 13F 申报文件 · 截至 2026-06-30

本期 13F-HR 中的全部持仓,以及相对上季度的变化。

13F 持仓,最新季度

来源SEC EDGAR13F-HR